Imeglimin Exhibits Novel Anti-Inflammatory Effects on High-Glucose-Stimulated Mouse Microglia through ULK1-Mediated Suppression of the TXNIP–NLRP3 Axis
Open Access
Abstract
Type 2 diabetes mellitus (T2DM) is an epidemiological risk factor for dementia and has been implicated in multifactorial pathologies, including neuroinflammation. In the present study, we aimed to elucidate the potential anti-inflammatory effects of imeglimin, a novel antidiabetic agent, on high-glucose (HG)-stimulated microglia. Mouse microglial BV2 cells were stimulated with HG in the presence or absence of imeglimin. We examined the effects of imeglimin on the levels of proinflammatory cytokines, intracellular reactive oxygen species (ROS), mitochondrial integrity, and components related to the inflammasome or autophagy pathways in these cells. Our results showed that imeglimin suppressed the HG-induced production of interleukin-1beta (IL-1β) by reducing the intracellular ROS levels, ameliorating mitochondrial dysfunction, and inhibiting the activation of the thioredoxin-interacting protein (TXNIP)–NOD-like receptor family pyrin domain containing 3 (NLRP3) axis. Moreover, the inhibitory effects of imeglimin on the TXNIP–NLRP3 axis depended on the imeglimin-induced activation of ULK1, which also exhibited novel anti-inflammatory effects without autophagy induction. These findings suggest that imeglimin exerted novel suppressive effects on HG-stimulated microglia through the ULK1–TXNIP–NLRP3 axis, and may, thereby, contribute to the development of innovative strategies to prevent T2DM-associated cognitive impairment.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP21K17557, JP22K07411, JP22K11720, JP22K07456, JP21H02835, JP22K19723, H29-NHO-01)
- National Hospital Organization for Collaborative Clinical Research (JP21K17557, JP22K07411, JP22K11720, JP22K07456, JP21H02835, JP22K19723, H29-NHO-01)
This publication has 44 references indexed in Scilit:
- Paeoniflorin, ferulic acid, and atractylenolide III improved LPS-induced neuroinflammation of BV2 microglia cells by enhancing autophagyJournal of Pharmacological Sciences, 2023
- Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implicationsActa Pharmaceutica Sinica B, 2022
- Interpreting global trends in type 2 diabetes complications and mortalityDiabetologia, 2021
- Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysisMetabolism, 2020
- High-glucose induces retinal pigment epithelium mitochondrial pathways of apoptosis and inhibits mitophagy by regulating ROS/PINK1/Parkin signal pathwayBiomedicine & Pharmacotherapy, 2019
- Exercise ameliorates high‐fat diet‐induced impairment of differentiation of adipose‐derived stem cells into neuron‐like cells in ratsJournal of Cellular Physiology, 2018
- An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's diseaseDiabetes Research and Clinical Practice, 2017
- Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respirationCell Death Discovery, 2016
- Phosphorylation of ULK1 by AMPK regulates translocation of ULK1 to mitochondria and mitophagyFEBS Letters, 2015
- High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathwaysActa Pharmacologica Sinica, 2011